EUVIMEDEUVIMED entdecken
Crossref

Clinical outcomes of superselective intra-arterial chemotherapy with concurrent radiotherapy (RADPLAT) for advanced maxillary sinus cancer: A single-institution experience

Nobumitsu Honda, Hirofumi Sei, Souhei Mitani, Yuichi Tomidokoro

Toukeibu Gan · 2026 · 52 (3) · 279-284

DOI: 10.5981/jjhnc.52.279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toukeibu Gan, 2026. Verfasst von Nobumitsu Honda und 3 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Most maxillary sinus cancers are diagnosed at an advanced stage (T3 or higher). Because of the rarity of the disease, the optimal treatment strategy has not been established. Recently, superselective intra-arterial chemotherapy with concurrent radiotherapy (RADPLAT) has been reported to achieve favorable local control while preserving organ function.

Methods

We conducted a retrospective review of 14 patients with advanced maxillary sinus cancer who underwent RADPLAT as the initial treatment at our institution between January 2012 and December 2021. Treatment characteristics, therapeutic response, survival outcomes, and treatment-related toxicities were evaluated.

Results

Among the 14 patients, the treatment response was complete response (CR) in 9 patients, partial response (PR) in 3 patients, and progressive disease (PD) in 2 patients. The 3-year overall survival (OS) rate was 78.6%.

Conclusion

RADPLAT using two intra-arterially administered chemotherapeutic agents demonstrated favorable clinical outcomes in patients with advanced maxillary sinus cancer at our institution. This approach may be effective even in patients with cervical lymph node metastasis. However, treatment-related toxicities were relatively frequent, indicating that careful systemic management is required during therapy.

Zitieren

APA

Honda, N., Sei, H., Mitani, S., & Tomidokoro, Y. (2026). Clinical outcomes of superselective intra-arterial chemotherapy with concurrent radiotherapy (RADPLAT) for advanced maxillary sinus cancer: A single-institution experience. Toukeibu Gan, 52(3), 279-284. https://doi.org/10.5981/jjhnc.52.279

Vancouver

Honda N, Sei H, Mitani S, Tomidokoro Y. Clinical outcomes of superselective intra-arterial chemotherapy with concurrent radiotherapy (RADPLAT) for advanced maxillary sinus cancer: A single-institution experience. Toukeibu Gan. 2026;52(3):279-284. doi:10.5981/jjhnc.52.279

BibTeX
@article{Honda2026,
  author = {Honda, Nobumitsu and Sei, Hirofumi and Mitani, Souhei and Tomidokoro, Yuichi},
  title = {Clinical outcomes of superselective intra-arterial chemotherapy with concurrent radiotherapy (RADPLAT) for advanced maxillary sinus cancer: A single-institution experience},
  journal = {Toukeibu Gan},
  year = {2026},
  volume = {52},
  number = {3},
  pages = {279--284},
  doi = {10.5981/jjhnc.52.279}
}
Kostenlos starten →